Dr. Kevin Michael Almerico, MD

Dr. Almerico practices at Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida.

Dr. Almerico's NPI, 1619339769, was assigned on March 27, 2016. Dr. Almerico graduated from St. Matthew's University in 2015. Dr. Almerico holds Florida license ME160252.

Dr. Almerico's primary practice is Baptist Health Baptist Hospital, at 8900 N Kendall Dr, Miami, FL 33176 in Miami-Dade County. The practice phone is (786) 596-1960.

Dr. Almerico's primary practice is Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida. Dr. Almerico is also affiliated with South Miami Hospital. The medical group on file is Miami Pulmonary Specialists. Dmand AI also links Dr. Almerico to 3 more hospitals, 1 breast imaging center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Almerico practices, 7 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Almerico's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Almerico is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Almerico's licenses on file in 2 states: Florida and Michigan.

Dmand AI lists asthma, chronic obstructive pulmonary disease (COPD), pneumonia and sleep apnea among the conditions Dr. Almerico treats.

CMS data shows 2,095 Medicare services from Dr. Almerico across 13 procedure codes in 2024, for 476 Medicare patients. Medicare paid $167,759 for them.

CMS counts 476 Medicare patients who saw Dr. Almerico in 2024. The largest group is 75 to 84, with 182 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 3.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Almerico's median patient age at 69, with 52% women.

In 2024, Dr. Almerico wrote 900 Medicare Part D claims for 207 patients. 37% of them were for generic drugs. CMS names the drug for 737 of them, across 19 drugs with 11 or more claims each, at $180,863 in total drug cost. In 2023, CMS named 81 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Almerico for performance year 2024, reported as part of a group. Dr. Almerico accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Almerico as offering telehealth.

CMS Open Payments shows 307 general payments to Dr. Almerico from 37 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 99% of the total. GlaxoSmithKline, LLC. paid the most, $1,848.

Dr. Almerico graduated from St. Matthew's University in 2015.

Dr. Almerico is in network with 9 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.